Recruiting

CT AngioScan vs. Coronary Angiogram

Sponsor:

Université de Sherbrooke

Code:

NCT01779986

Conditions

Coronary Artery Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The use of CT Coronary Angioscan (CT-AS) is gaining popularity, but its exact value as evaluation of CAD requires confirmation. We intend to compare the results of CT-AS and convention coronary angiogram results in patients who are scheduled for an ascending aorta aneurysm reparation surgery. These examens are standard of care before this surgery, so there is no additional danger or disadvantage for the patient. We hope to confirm that CT-AS is a reliable screening test for CAD in patient undergoing heart surgery for other reason than CAD.

Conditions

Coronary Artery Disease

Study ID

NCT01779986

Start date

Jan, 2013

Status verified date

Jan, 2013

Completion date

Feb, 2015

Anticipated

Primary completion date

Feb, 2015

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Ascending aorta aneurysm waiting for surgical correction
  • Willing to participate
  • Needing a Coronary angiogram and a CT-AS for medical reasons

Exclusion Criteria:

  • Refuse to participate
  • Allergy to contrast material
  • Incomplete results or having one of the test done in another hospital
  • Arrythmia
  • More than 6 months between the two exams

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Presence of CAD [ Time Frame: less than 6 monthes between two tests ]

Central Contacts and Locations

Locations

CHUS Fleurimont

Recruiting

Sherbrooke, Quebec, Canada, J1H 5N4

Contacts

Principal Investigator:

Gérald Gahide, MD

More Information

Sponsor

Université de Sherbrooke

Last update posted

Jan 30, 2013

Last verified

Jan, 2013

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Université de Sherbrooke on 2013-01-30.